# Krystal Biotech Q3 Product Revenue Rises 30% to $127.3 Million

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/46482
Published: 2026-11-02T13:45:40.000Z
Updated: 2026-11-02T13:45:40.000Z
Section: Business

> GAAP earnings per share were $2.05. Cash, cash equivalents and investments totaled $1.2 billion as of Sept. 30, 2026.

Krystal Biotech, Inc. posted $127.3 million in net product revenue for the third quarter, up from $97.8 million a year earlier, a 30.2% increase.

GAAP earnings per share were $2.05. Cash, cash equivalents and investments totaled $1.2 billion as of Sept. 30, 2026.

The results follow TokenPost’s earlier [preview of the company’s Q3 estimates](<https://www.tokenpost.com/news/business/44962>).



## Links in this article

- [preview of the company’s Q3 estimates](https://www.tokenpost.com/news/business/44962)